No ano passado, Abbott Laboratories gerou US$ 8.00B em seu segmento de melhor desempenho, Diabetes Care. A região United States teve a maior contribuição, com US$ 17.13B no período. No último trimestre, Abbott Laboratories registrou receita de US$ 2.19B no período encerrado em 2026-06-30, proveniente principalmente do segmento Diabetes Care. A região All other Countries teve a maior contribuição, com receita de US$ 7.38B.

Por Empresa

Receita

Proporção

Anual

Anual

Trimestral

Diabetes Care

Core Laboratory

Adult Nutritionals

Key Emerging Markets

Pediatric Nutritionals

Vascular

Electrophysiology

Rhythm Management

Structural Heart

Rapid Diagnostics

Heart Failure

Other

Neuromodulation

Point of Care

Molecular

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Diabetes Care

8.00B(18.04%)

6.80B(16.22%)

5.76B(14.36%)

4.76B(10.90%)

4.33B(10.05%)

3.27B(9.44%)

Core Laboratory

5.36B(12.09%)

5.24B(12.48%)

5.16B(12.86%)

4.89B(11.20%)

5.13B(11.90%)

4.47B(12.93%)

Adult Nutritionals

4.48B(10.10%)

4.39B(10.46%)

4.22B(10.52%)

3.98B(9.11%)

4.00B(9.28%)

3.52B(10.17%)

Key Emerging Markets

4.17B(9.40%)

3.86B(9.20%)

3.81B(9.49%)

3.73B(8.54%)

3.54B(8.22%)

3.21B(9.27%)

Pediatric Nutritionals

3.97B(8.96%)

4.02B(9.59%)

3.93B(9.81%)

3.48B(7.97%)

4.30B(9.98%)

4.13B(11.92%)

Vascular

3.00B(6.76%)

2.84B(6.76%)

2.68B(6.68%)

2.48B(5.69%)

2.65B(6.16%)

2.34B(6.76%)

Electrophysiology

2.76B(6.24%)

2.47B(5.88%)

2.19B(5.47%)

1.93B(4.41%)

1.91B(4.43%)

1.58B(4.56%)

Rhythm Management

2.65B(5.98%)

2.39B(5.70%)

2.25B(5.62%)

2.12B(4.85%)

2.20B(5.10%)

1.91B(5.53%)

Structural Heart

2.52B(5.69%)

2.25B(5.35%)

1.94B(4.85%)

1.71B(3.92%)

1.61B(3.74%)

1.25B(3.60%)

Rapid Diagnostics

2.45B(5.54%)

3.00B(7.14%)

3.69B(9.20%)

10.18B(23.31%)

8.55B(19.86%)

4.38B(12.64%)

Heart Failure

1.45B(3.27%)

1.28B(3.05%)

1.16B(2.89%)

920.00M(2.11%)

889.00M(2.06%)

740.00M(2.14%)

Other

1.39B(3.13%)

1.35B(3.22%)

1.27B(3.17%)

1.20B(2.74%)

1.23B(2.86%)

1.16B(3.35%)

Neuromodulation

1.01B(2.28%)

962.00M(2.29%)

890.00M(2.22%)

770.00M(1.76%)

781.00M(1.81%)

702.00M(2.03%)

Point of Care

606.00M(1.37%)

588.00M(1.40%)

565.00M(1.41%)

525.00M(1.20%)

536.00M(1.24%)

516.00M(1.49%)

Molecular

517.00M(1.17%)

521.00M(1.24%)

574.00M(1.43%)

995.00M(2.28%)

1.43B(3.31%)

1.44B(4.16%)

Por Região

Receita

Proporção

Anual

Anual

Trimestral

United States

All other Countries

Germany

China

India

Switzerland

Japan

United Kingdom

India

The Netherlands

Canada

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

17.13B(38.63%)

16.32B(38.91%)

15.45B(38.53%)

18.14B(41.56%)

16.64B(38.63%)

13.02B(37.63%)

11.40B(35.73%)

All other Countries

15.98B(36.05%)

14.85B(35.39%)

14.08B(35.11%)

14.84B(34.00%)

15.52B(36.02%)

12.58B(36.35%)

11.53B(36.15%)

Germany

2.76B(6.22%)

2.54B(6.05%)

2.35B(5.85%)

2.34B(5.36%)

2.57B(5.97%)

2.11B(6.09%)

1.75B(5.49%)

China

1.91B(4.30%)

2.11B(5.04%)

2.25B(5.62%)

2.13B(4.89%)

2.39B(5.55%)

1.97B(5.68%)

2.35B(7.35%)

India

1.87B(4.22%)

--(--)

Switzerland

1.87B(4.22%)

1.75B(4.16%)

1.64B(4.08%)

1.34B(3.06%)

1.31B(3.05%)

1.14B(3.29%)

1.07B(3.35%)

Japan

1.48B(3.33%)

1.44B(3.44%)

1.51B(3.77%)

1.93B(4.43%)

1.70B(3.93%)

1.39B(4.00%)

1.44B(4.50%)

United Kingdom

1.34B(3.02%)

--(--)

India

--(--)

1.82B(4.33%)

1.75B(4.36%)

1.65B(3.78%)

1.56B(3.62%)

1.32B(3.82%)

1.40B(4.38%)

The Netherlands

--(--)

1.12B(2.68%)

1.07B(2.68%)

--(--)

1.08B(3.13%)

975.00M(3.06%)

Canada

--(--)

1.28B(2.93%)

1.39B(3.22%)

--(--)